1556 related articles for article (PubMed ID: 29992857)
1. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
2. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW
JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Jones WS; Baumgartner I; Hiatt WR; Heizer G; Conte MS; White CJ; Berger JS; Held P; Katona BG; Mahaffey KW; Norgren L; Blomster J; Millegård M; Reist C; Patel MR; Fowkes FG;
Circulation; 2017 Jan; 135(3):241-250. PubMed ID: 27840336
[TBL] [Abstract][Full Text] [Related]
7. Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Berger JS; Katona BG; Jones WS; Patel MR; Norgren L; Baumgartner I; Blomster J; Mahaffey KW; Held P; Millegård M; Heizer G; Reist C; Fowkes FG; Hiatt WR
Am Heart J; 2016 May; 175():86-93. PubMed ID: 27179727
[TBL] [Abstract][Full Text] [Related]
8. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
[TBL] [Abstract][Full Text] [Related]
9. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
10. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Pereira NL; Farkouh ME; So D; Lennon R; Geller N; Mathew V; Bell M; Bae JH; Jeong MH; Chavez I; Gordon P; Abbott JD; Cagin C; Baudhuin L; Fu YP; Goodman SG; Hasan A; Iturriaga E; Lerman A; Sidhu M; Tanguay JF; Wang L; Weinshilboum R; Welsh R; Rosenberg Y; Bailey K; Rihal C
JAMA; 2020 Aug; 324(8):761-771. PubMed ID: 32840598
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention.
Xi Z; Zhou Y; Zhao Y; Liu X; Liang J; Chai M; Yu Y; Liu W
Cardiovasc Drugs Ther; 2020 Apr; 34(2):179-188. PubMed ID: 32140798
[TBL] [Abstract][Full Text] [Related]
12. Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.
Samsky MD; Hellkamp A; Hiatt WR; Fowkes FGR; Baumgartner I; Berger JS; Katona BG; Mahaffey KW; Norgren L; Blomster JI; Rockhold FW; DeVore AD; Patel MR; Jones WS
J Am Heart Assoc; 2021 Jun; 10(12):e018684. PubMed ID: 34056910
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR;
N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717
[TBL] [Abstract][Full Text] [Related]
14. Acute Limb Ischemia in Peripheral Artery Disease.
Hess CN; Huang Z; Patel MR; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Jones WS; Katona B; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Circulation; 2019 Aug; 140(7):556-565. PubMed ID: 31238713
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
Gao C; Tomaniak M; Takahashi K; Kawashima H; Wang R; Hara H; Ono M; Montalescot G; Garg S; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; van Geuns RJ; Hamm C; Steg PG; Onuma Y; Angiolillo DJ; Serruys PW
Cardiovasc Diabetol; 2020 Oct; 19(1):179. PubMed ID: 33066794
[TBL] [Abstract][Full Text] [Related]
16. Stroke in Patients With Peripheral Artery Disease.
Kolls BJ; Sapp S; Rockhold FW; Jordan JD; Dombrowski KE; Fowkes FGR; Mahaffey KW; Berger JS; Katona BG; Blomster JI; Norgren L; Abramson BL; Leiva-Pons JL; Prieto JC; Sokurenko G; Hiatt WR; Jones WS; Patel MR
Stroke; 2019 Jun; 50(6):1356-1363. PubMed ID: 31092165
[TBL] [Abstract][Full Text] [Related]
17. Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
Szarek M; Hess C; Patel MR; Jones WS; Berger JS; Baumgartner I; Katona B; Mahaffey KW; Norgren L; Blomster J; Rockhold FW; Hsia J; Fowkes FGR; Bonaca MP
J Am Heart Assoc; 2022 Jun; 11(11):e025504. PubMed ID: 35621222
[TBL] [Abstract][Full Text] [Related]
18. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
19. Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice.
Mullen L; Meah MN; Elamin A; Aggarwal S; Shahzad A; Shaw M; Hasara J; Rashid M; Fisher M; Ali T; Patel B; Ding WY; Grainger R; Heseltine T; Kirmani BH; Obeidat M; Kasolo Y; Thatchil J; Khand A
J Am Heart Assoc; 2021 Apr; 10(8):e019467. PubMed ID: 33834845
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention.
Li J; Qiu H; Yan L; Guo T; Wang Y; Li Y; Zheng J; Tang Y; Xu B; Qiao S; Yang Y; Gao R
Curr Med Res Opin; 2020 Nov; 36(11):1739-1745. PubMed ID: 32945695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
